Piperidine derivatives as nonprostanoid IP receptor agonists 2

Add time:08/29/2019    Source:sciencedirect.com

We searched for a strong and selective nonprostanoid IP agonist bearing piperidine and benzanilide moieties. Through optimization of substituents on the benzanilide moiety, the crucial part of the agonist, 43 (2-((1-(2-(N-(4-tolyl)benzo[d][1,3]dioxole-5-carboxamido)ethyl)piperidin-4-yl)oxy)acetic acid monohydrate monohydrochloride) was discovered and exhibited strong platelet aggregation inhibition (IC50 = 21 nM) and 100-fold selectivity for IP receptor over other PG receptors. The systemic exposure level and bioavailability after oral administration of 43 were also good in dog.

We also recommend Trading Suppliers and Manufacturers of PIPERIDIN-2-YL-ACETIC ACID HYDROCHLORIDE (cas 19615-30-6). Pls Click Website Link as below: cas 19615-30-6 suppliers

Prev:Analytical MethodsNew short and general synthesis of three key Maillard flavour compounds: 2-Acetyl-1-pyrroline, 6-acetyl-1,2,3,4-tetrahydropyridine and 5-acetyl-2,3-dihydro-4H-1,4-thiazine
Next:Development and validation of a method for the analysis of hydroxyzine hydrochloride in extracellular solution used in in vitro preclinical safety studies)